At what enterprise value was DAREN TECHNOLOGY acquired in 2026?

During the acquisition of DAREN TECHNOLOGY by CIMG in 2026, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 20M - 50M USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of DAREN TECHNOLOGY when it was acquired by CIMG?

The exact EV/EBITDA multiple for DAREN TECHNOLOGY is available on mynth capital. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was DAREN TECHNOLOGY acquired by CIMG?

DAREN TECHNOLOGY was acquired by CIMG in 2026.

What was the revenue of DAREN TECHNOLOGY at the time of the deal?

The revenue of DAREN TECHNOLOGY at the time of the deal is estimated to be in the range of 10M - 30M USD. Register for free to access the full transaction report and exact valuation multiples.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the DAREN TECHNOLOGY acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DAREN TECHNOLOGY deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://intellectia.ai/news/stock/cimg-acquires-100-equity-of-daren-technology

← DATABASE

Home Database Healthcare & PharmaDAREN TECHNOLOGY

02/2026

DAREN TECHNOLOGY acquired by CIMG

CHINA Life Sciences / Pharma & Biotech / R&D Biotech EV 20M - 50M USD

Context

CIMG, through its subsidiary DZR, signed an agreement to acquire 100% of Daren Technology for approximately $40M in stock. The transaction features a highly structured Phased Payment consideration (6%, 14%, 28%, and 52%) released over 3.5 years. This earn-out structure is strictly tied to Daren achieving aggressive audited revenue targets, starting at $29M in 2026 and scaling to $257M by September 2029. This structure ensures alignment between the acquisition cost and the realized growth of the target's biopharmaceutical activities.

DAREN TECHNOLOGY, which reported an EBITDA margin of in 2026, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Daren Technology is a specialized firm in the biopharmaceutical sector, focused on technological innovation and model integration within the drug development value chain. It serves as a new growth engine for diversified Corporate groups looking to enter high-growth life sciences markets.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2026

2025

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2026	SIPAREX	WINNCARE	FRANCE	Medical Devices
03/2026	RESONETICS	RESOLUTION MEDICAL	UNITED STATES	Medical Devices
02/2026	VIVO CAPITAL	DUTSCHER	FRANCE	Medical Consumables
02/2026	IMA GROUP	PROSYS	IRELAND	Medical Devices
02/2026	NORD HOLDING	HALLMARQ VETERINARY IMAGING	UNITED KINGDOM	Diagnostic Equipment
01/2026	YOTTA CAPITAL	VILLARD	FRANCE	Medical Consumables
01/2026	FAGRON	UNIVERSITY COMPOUNDING PHARMACY (UCP)	UNITED STATES	Compounding
12/2025	CHARTERHOUSE	WINBACK	FRANCE	Medical Devices
11/2025	ANJAC BEAUTY & HEALTH	HEALTH CHAIN GROUP (HCG)	SLOVENIA	CDMO
11/2025	PFIZER	METSERA	UNITED STATES	R&D Biotech

REFERENCES

Valuation range: EV 20M - 50M USD

Revenue range: 10M - 30M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DAREN TECHNOLOGY by CIMG are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.